Summary
In 2015, four million people worldwide died because of the aftermaths of obesity (7% of total deaths), and in 2030, half of humankind is expected to be overweight. Lifestyle interventions in subjects with obesity can prevent the development of obesity-induced metabolic dysfunction but need personalization in order to become effective for diabetes and cardiovascular disease prevention. Visceral adiposity and adipocyte hypertrophy are phenotypes strongly linked to metabolic dysfunction in subjects with obesity. Visceral adiposity can be non-invasively measured using Magnetic Resonance Imaging (MRI). Adipocyte size measurements are however nowadays only feasible using highly invasive biopsy procedures that cause severe patient discomfort, hold a risk for complications and are therefore rarely performed in the personalization of lifestyle interventions. The ongoing ProFatMRI research program (ERC-StG 677661) focuses on the development of an MRI platform to non-invasively assess fat microstructure. In the present proof of concept (PoC) project, we will translate the lipid droplet size measurement approaches successfully developed within ProFatMRI into an effective and reproducible toolkit (FatVirtualBiopsy) for non-invasive in vivo human adipocyte size measurement. The present PoC project encompasses the evaluation and the technical adjustment of the adipocyte size measurement in the real-life scenario involving a lifestyle intervention in subjects with obesity, the development of a prototype and the adoption of an intellectual property strategy. The PoC project will result in a non-invasive imaging toolkit that can be integrated into clinical prevention, targeting a wide range of medical specialists involved in obesity treatment. FatVirtualBiopsy will therefore contribute to transform the personalization of lifestyle interventions and drastically improve their effectiveness in subjects with obesity towards diabetes and cardiovascular disease prevention.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/875488 |
| Start date: | 01-03-2020 |
| End date: | 31-01-2022 |
| Total budget - Public funding: | - 150 000,00 Euro |
Cordis data
Original description
In 2015, four million people worldwide died because of the aftermaths of obesity (7% of total deaths), and in 2030, half of humankind is expected to be overweight. Lifestyle interventions in subjects with obesity can prevent the development of obesity-induced metabolic dysfunction but need personalization in order to become effective for diabetes and cardiovascular disease prevention. Visceral adiposity and adipocyte hypertrophy are phenotypes strongly linked to metabolic dysfunction in subjects with obesity. Visceral adiposity can be non-invasively measured using Magnetic Resonance Imaging (MRI). Adipocyte size measurements are however nowadays only feasible using highly invasive biopsy procedures that cause severe patient discomfort, hold a risk for complications and are therefore rarely performed in the personalization of lifestyle interventions. The ongoing ProFatMRI research program (ERC-StG 677661) focuses on the development of an MRI platform to non-invasively assess fat microstructure. In the present proof of concept (PoC) project, we will translate the lipid droplet size measurement approaches successfully developed within ProFatMRI into an effective and reproducible toolkit (FatVirtualBiopsy) for non-invasive in vivo human adipocyte size measurement. The present PoC project encompasses the evaluation and the technical adjustment of the adipocyte size measurement in the real-life scenario involving a lifestyle intervention in subjects with obesity, the development of a prototype and the adoption of an intellectual property strategy. The PoC project will result in a non-invasive imaging toolkit that can be integrated into clinical prevention, targeting a wide range of medical specialists involved in obesity treatment. FatVirtualBiopsy will therefore contribute to transform the personalization of lifestyle interventions and drastically improve their effectiveness in subjects with obesity towards diabetes and cardiovascular disease prevention.Status
CLOSEDCall topic
ERC-2019-POCUpdate Date
27-04-2024
Images
No images available.
Geographical location(s)
Search
